New research suggests that use of depot medroxyprogesterone acetate may be associated with an increased risk for fracture in women, particularly in those with longer treatment duration and multiple ...
The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for prostate ...
Stability of Parental Understanding of Random Assignment in Childhood Leukemia Trials: An Empirical Examination of Informed Consent Thalidomide was started at 100 mg/d orally (PO) and escalated by 100 ...
The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns. Depo-Provera ...
Cyproterone, medroxyprogesterone most effective for reducing hot flushes in men with prostate cancer
Please provide your email address to receive an email when new articles are posted on . Men with prostate cancer who reported having significant hot flushes during androgen suppression treatment had a ...
(HealthDay News) – Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results